RECRUITING

Identifying and Characterizing Preclinical MS

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research study is to try and identify risk factors and biologic changes that suggest that someone may go on to develop multiple sclerosis before a person has shown any symptoms of the disease.

Official Title

Identifying and Characterizing Preclinical MS

Quick Facts

Study Start:2022-06-21

Study Completion:2033-06-30

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05787795

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Age 18+ * Having one or more risk factors for multiple sclerosis, including one or more of the below: * Individuals known to have a radiologically isolated syndrome * Individuals with a family history of multiple sclerosis (first degree family member) * Individuals with personal risk factors, which are known to include smoking, obesity, Epstein Barr virus infections, Vitamin D deficiency, genetic risk score	* Currently pregnant * Diagnosis of multiple sclerosis or any ongoing, systemic autoimmune disease * Ongoing treatment with immunosuppressive medications

Inclusion Criteria

Exclusion Criteria

* Age 18+
* Having one or more risk factors for multiple sclerosis, including one or more of the below:
* Individuals known to have a radiologically isolated syndrome
* Individuals with a family history of multiple sclerosis (first degree family member)
* Individuals with personal risk factors, which are known to include smoking, obesity, Epstein Barr virus infections, Vitamin D deficiency, genetic risk score

* Currently pregnant
* Diagnosis of multiple sclerosis or any ongoing, systemic autoimmune disease
* Ongoing treatment with immunosuppressive medications

Contacts and Locations

Study Contact

Erin Longbrake, MD

CONTACT

860-287-6100

erin.longbrake@yale.edu

Principal Investigator

Erin Longbrake, MD

PRINCIPAL_INVESTIGATOR

Yale University

Study Locations (Sites)

Yale University

North Haven, Connecticut, 06473

United States

Collaborators and Investigators

Sponsor: Yale University

Erin Longbrake, MD, PRINCIPAL_INVESTIGATOR, Yale University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-06-21

Study Completion Date2033-06-30

Study Record Updates

Study Start Date2022-06-21

Study Completion Date2033-06-30

Terms related to this study

Additional Relevant MeSH Terms

Multiple Sclerosis